Astellas Pharma reported 137.11B in Selling and Administration Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Astellas Pharma 4503:JP 137.11B 4.16B
Chugai Pharma 4519:JP 23.08B 3.29B
Daiichi Sankyo 4568:JP 79.12B 24.69B
Eisai 4523:JP 74.73B 4.69B
Kyowa Hakko Kirin 4151:JP 32.94B 3.93B
M3 2413:JP 13.06B 830M
Otsuka Holdings 4578:JP 148.83B 14.61B
Shionogi 4507:JP 21.75B 3.92B
Sumitomo Dainippon 4506:JP 62.06B 18.71B
Takeda 4502:JP 219.84B 14.55B
Terumo 4543:JP 58.14B 3.88B